Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Triple-negative breast cancer Stories

2011-01-05 16:00:00

BRIDGEWATER, N.J., Jan. 5, 2011 /PRNewswire/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and its wholly-owned subsidiary, BiPar Sciences, today announced that The New England Journal of Medicine (NEJM) published the final phase II data for the investigational drug iniparib* (BSI-201) demonstrating significant clinical benefit in women with metastatic triple negative breast cancer (mTNBC) when iniparib was administered in combination with chemotherapy agents gemcitabine/carboplatin....

2010-12-10 17:30:00

WALTHAM, Mass., Dec. 10, 2010 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces results from two preclinical studies on entinostat, an orally bioavailable, highly selective, class I histone deacetylase (HDAC) inhibitor, in animal models of breast cancer. The data are being presented as oral poster discussions at the San Antonio Breast Cancer Symposium December 8 through December 12 in San Antonio Texas. The following poster discussions...

2010-10-18 15:48:00

DETROIT, Oct. 18 /PRNewswire-USNewswire/ -- Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit have received a nearly $3 million, five-year research project (RO1) grant from the National Institutes of Health to study a potentially ground-breaking immunotherapy treatment for women with one of the deadliest forms of breast cancer - triple-negative breast cancer. The research is exclusive to the Karmanos Cancer Institute. (Logo:...

2010-10-12 18:42:28

Investigators from the Slone Epidemiology Center at Boston University School of Medicine (BUSM) have reported that African American women who consume more vegetables are less likely to develop estrogen receptor-negative breast cancer than women with low vegetable intake. The study results, published in the American Journal of Epidemiology, were based on data from the Black Women's Health Study (BWHS), a large follow-up study of 59,000 African American women from across the U.S. conducted by...

2010-10-06 11:11:11

(Ivanhoe Newswire) "“ Breast cancer is the most common cancer diagnosis in African American women. This study shows that vigorous exercise of more than two hours per week reduces the risk of developing breast cancer in postmenopausal African-American women by 64 percent, compared to women of the same race who do not exercise. "People often want to know what they can do to reduce their risk of disease, and the study found that just two or more hours of vigorous activity per week can make...

2010-10-04 14:47:45

Puerto Rican women who had breast cancer that lacked estrogen and progesterone receptors and did not overexpress the HER2neu protein (triple-negative) had worse survival than those with other types of invasive breast cancer, according to a study presented at the Third AACR Conference on The Science of Cancer Health Disparities, held Sept. 30 "“ Oct. 3, 2010. "As the incidence of breast cancer rises in Puerto Rico, following U.S. trends, it is important to understand the association of...

2010-10-04 13:35:18

Vigorous exercise of more than two hours per week reduces the risk of developing breast cancer in postmenopausal African-American women by 64 percent, compared to women of the same race who do not exercise, according to researchers at Georgetown Lombardi Comprehensive Cancer Center. Results were presented at the Third AACR Conference on The Science of Cancer Health Disparities, held Sept. 30 to Oct. 3, 2010. "People often want to know what they can do to reduce their risk of disease, and we...

2010-10-01 09:36:58

(Ivanhoe Newswire) -- Patients with triple-negative breast cancer can now receive more personalized treatment. The may have a unique biomarker that would enable them to receive more targeted therapy, a new study says. According to The Breast cancer Foundation, triple-negative cancer is not one disease, but many different forms of cancer all originating in the breast. Because triple-negative cancers are breast cancers that have tested negative for estrogen receptors, these cancers do not...

2010-09-30 19:24:45

Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same disease without the deleterious genetic mutation, according to researchers at The University of Texas MD Anderson Cancer Center. The findings may offer a direction for study of personalized therapy in this select group of triple negative breast cancer patients, as well as highlight the unique need for genetic testing in a patient...

2010-09-20 18:50:44

Individuals with disrupting mutations in the BRCA1 gene are known to be at substantially increased risk of breast cancer throughout their lives. Now, discoveries from an international research team led by Mayo Clinic researchers show that some of those persons may possess additional genetic variants that modify their risk. These new findings enhancing individualized medicine appear in the current Nature Genetics. "These findings should be useful in helping determine individual risk for breast...